Boothbay Fund Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.28M	Buy	+134,945	New	+$3.68M	0.1%	361
2023 Q2	–	Sell	-19,576	Closed	-$704K	–	1894
2023 Q1	$704K	Sell	19,576 -11,697	-37%	-$505K	0.02%	1140
2022 Q4	$1.39M	Sell	31,273 -5,845	-16%	-$209K	0.04%	752
2022 Q3	$1.04M	Sell	37,118 -24,947	-40%	-$765K	0.03%	847
2022 Q2	$1.67M	Hold	62,065	–	–	0.05%	613
2022 Q1	$2.11M	Buy	62,065 +16,615	+37%	+$531K	0.06%	564
2021 Q4	$1.76M	Buy	45,450 +19,041	+72%	+$830K	0.06%	523
2021 Q3	$1.43M	Sell	26,409 -25,929	-50%	-$1.22M	0.05%	591
2021 Q2	$1.75M	Sell	52,338 -21,861	-29%	-$600K	0.07%	435
2021 Q1	$1.53M	Sell	74,199 -105,471	-59%	-$2.42M	0.08%	422
2020 Q4	$3.15M	Sell	179,670 -6,447	-3%	-$116K	0.16%	156
2020 Q3	$2.76M	Sell	186,117 -22,719	-11%	-$266K	0.22%	145
2020 Q2	$2.71M	Buy	+208,836	New	+$926K	0.23%	140